You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 208564


✉ Email this page to a colleague

« Back to Dashboard


NDA 208564 describes IMVEXXY, which is a drug marketed by Mayne Pharma and is included in one NDA. It is available from two suppliers. There are twenty patents protecting this drug. Additional details are available on the IMVEXXY profile page.

The generic ingredient in IMVEXXY is estradiol. There are seventy-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.
Summary for 208564
Tradename:IMVEXXY
Applicant:Mayne Pharma
Ingredient:estradiol
Patents:20
Pharmacology for NDA: 208564
Mechanism of ActionEstrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for 208564
Suppliers and Packaging for NDA: 208564
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IMVEXXY estradiol INSERT;VAGINAL 208564 NDA Mayne Pharma LLC 50261-104 50261-104-02 1 BLISTER PACK in 1 CARTON (50261-104-02) / 2 INSERT in 1 BLISTER PACK
IMVEXXY estradiol INSERT;VAGINAL 208564 NDA Mayne Pharma LLC 50261-104 50261-104-08 1 BLISTER PACK in 1 CARTON (50261-104-08) / 8 INSERT in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INSERT;VAGINALStrength0.004MG
Approval Date:May 29, 2018TE:RLD:Yes
Patent:⤷  Sign UpPatent Expiration:Dec 20, 2033Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF A SYMPTOM OF VULVAR AND VAGINAL ATROPHY
Patent:⤷  Sign UpPatent Expiration:Dec 20, 2033Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF DYSPAREUNIA
Patent:⤷  Sign UpPatent Expiration:Dec 20, 2033Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF A SYMPTOM OF VULVAR AND VAGINAL ATROPHY

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.